Related Experiment Video

Updated: Mar 26, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

6.2K

Diabetes medications: Impact on inflammation and wound healing

Jay J Salazar1, William J Ennis2, Timothy J Koh3

  • 1Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, USA.

Journal of Diabetes and Its Complications
|January 23, 2016
PubMed

Insights

Certain diabetes medications may help heal chronic diabetic wounds by reducing inflammation. Further research is needed to guide personalized treatment for better glycemic control and wound healing.

Area of Science:

  • Endocrinology
  • Wound Healing Research
  • Pharmacology

Background:

  • Chronic wounds are a significant complication for diabetic patients, often leading to amputation.
  • These wounds are characterized by a persistent inflammatory state with elevated pro-inflammatory mediators.
  • Existing type 2 diabetes medications may possess anti-inflammatory properties beneficial for wound healing.

Purpose of the Study:

  • To review the potential of various diabetes medications to promote chronic wound healing.
  • To evaluate the anti-inflammatory effects of insulin, metformin, sulfonylureas, thiazolidinediones, and DPP-4 inhibitors on wound healing.

Main Methods:

  • Systematic review of human and animal studies.
  • Analysis of research on inflammation and wound healing mechanisms.
  • Evaluation of medication effects on inflammatory markers and healing processes.

Main Results:

  • Diabetic medications show potential in preventing wound healing arrest by modulating inflammation.
  • These drugs can promote healing by downregulating pro-inflammatory cytokines and matrix metalloproteinases.
  • Evidence suggests benefits in upregulating growth factors, stimulating angiogenesis, and increasing epithelization.

Conclusions:

  • Specific diabetes medications may offer therapeutic benefits for chronic wound healing beyond glycemic control.
  • No current clinical guidelines exist for using these medications to impact wound healing.
  • Further research is encouraged to personalize diabetes treatment for optimal wound healing outcomes.
Keywords:
DPP-4 inhibitorInsulinMetforminSulfonylureaThiazolidinedioneWound healing

More Related Videos

Protocol to Create Chronic Wounds in Diabetic Mice06:55

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

22.0K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.1K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
919
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.0K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
848
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K